Jacobs was tapped as Novavax’s CEO for his commercial expertise and success launching new drugs.
Although, under ordinary circumstances, Jacobs could be an effective CEO, given Novavax’s numerous challenges, the company needs a turnaround expert and it's unlikely that Jacobs will succeed
For a CEO, he is above average. But he will not be a visionary person who will be a transformational leader.
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.